Antyoksydacyjne właściwości i przeciwmiażdżycowe działanie paraoksonazy 1

This overview will discuss the Paraoxonase 1 (PON1) in arteriosclerosis diseases. Atherosclerosis is one of lifestyle diseases and affects greater number of people. Ischemic heart disease, acute coronary syndromes or stroke are the clinical symptoms of atherosclerosis and are the most common cause of morbidity especially in middle and old age people. In atherosclerosis, in the space between the endothelium and the muscular layer in the wall of a blood vessel, accumulates deposits consisting of macrophages, lipoprotein, low density foam cells and extracellular concentrations of cholesterol. In this way fatty streaks are formed which are early stage atherosclerotic lesions. With the passage of time they are joined by elements of fibrous connective tissue that undergo hypertrophy. They begin to surround primarily created the fireplace of inflammation and separate them from the rest of the blood vessel [1]. Further research if needed to better understanding the mechanisms related to atherosclerosis development and plaque instability because it may have important clinical implications for the identification of high-risk patients. The present review tries to summarize the current knowledge on the role of PON1 in the formation of atherosclerotic plaque is the goal of current research [2].